CL2017000587A1 - Derivados de tetrahidroquinolina como inhibidores de bromodominio - Google Patents
Derivados de tetrahidroquinolina como inhibidores de bromodominioInfo
- Publication number
- CL2017000587A1 CL2017000587A1 CL2017000587A CL2017000587A CL2017000587A1 CL 2017000587 A1 CL2017000587 A1 CL 2017000587A1 CL 2017000587 A CL2017000587 A CL 2017000587A CL 2017000587 A CL2017000587 A CL 2017000587A CL 2017000587 A1 CL2017000587 A1 CL 2017000587A1
- Authority
- CL
- Chile
- Prior art keywords
- bromodomain inhibitors
- tetrahydroquinoline derivatives
- tetrahydroquinoline
- derivatives
- bromodomain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
<p>LA PRESENTE INVENCIÓN SE REFIERE A NUEVOS COMPUESTOS, A COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN TALES COMPUESTOS Y A SU USO EN TERAPIA.</p>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462049449P | 2014-09-12 | 2014-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2017000587A1 true CL2017000587A1 (es) | 2017-10-06 |
Family
ID=54065889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2017000587A CL2017000587A1 (es) | 2014-09-12 | 2017-03-09 | Derivados de tetrahidroquinolina como inhibidores de bromodominio |
Country Status (35)
Country | Link |
---|---|
US (1) | US10059699B2 (es) |
EP (1) | EP3191476B1 (es) |
JP (1) | JP6531167B2 (es) |
KR (1) | KR20170054421A (es) |
CN (1) | CN106687453B (es) |
AR (1) | AR101806A1 (es) |
AU (1) | AU2015314184B2 (es) |
BR (1) | BR112017004580A2 (es) |
CA (1) | CA2958159A1 (es) |
CL (1) | CL2017000587A1 (es) |
CO (1) | CO2017001601A2 (es) |
CR (1) | CR20170090A (es) |
CY (1) | CY1121369T1 (es) |
DK (1) | DK3191476T3 (es) |
DO (1) | DOP2017000058A (es) |
EA (1) | EA031679B9 (es) |
ES (1) | ES2705623T3 (es) |
HR (1) | HRP20182064T1 (es) |
HU (1) | HUE041694T2 (es) |
IL (1) | IL250397A0 (es) |
LT (1) | LT3191476T (es) |
MA (1) | MA40366A (es) |
MX (1) | MX2017003219A (es) |
PE (1) | PE20170675A1 (es) |
PH (1) | PH12017500348A1 (es) |
PL (1) | PL3191476T3 (es) |
PT (1) | PT3191476T (es) |
RS (1) | RS58135B1 (es) |
SG (1) | SG11201701043UA (es) |
SI (1) | SI3191476T1 (es) |
TR (1) | TR201820050T4 (es) |
TW (1) | TWI686389B (es) |
UY (1) | UY36292A (es) |
WO (1) | WO2016038120A1 (es) |
ZA (1) | ZA201700883B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2970283B1 (en) | 2013-03-14 | 2020-11-11 | Boehringer Ingelheim International GmbH | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c |
AP2017009733A0 (en) | 2014-09-12 | 2017-02-28 | Boehringer Ingelheim Int | Spirocyclic inhibitors of cathepsin c |
US11028051B2 (en) * | 2016-12-13 | 2021-06-08 | St. Jude Children's Research Hospital | Tetrahydroquinoline-based bromodomain inhibitors |
JP2022509534A (ja) | 2018-10-30 | 2022-01-20 | ニューベイション・バイオ・インコーポレイテッド | Bet阻害剤としてのヘテロ環式化合物 |
EP3997070A4 (en) | 2019-07-02 | 2023-07-26 | Nuvation Bio Inc. | HETEROCYCLIC COMPOUNDS USED AS BET INHIBITORS |
EP4095128A1 (en) | 2021-05-25 | 2022-11-30 | Centre national de la recherche scientifique | Tetrahydroquinoline (thq) coumpounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010113498A1 (ja) * | 2009-03-31 | 2010-10-07 | 興和株式会社 | テトラヒドロキノリン化合物を有効成分とする貧血の予防及び/又は治療剤 |
GB0919431D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
GB0919432D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Use |
GB0919434D0 (en) * | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
GB201106743D0 (en) | 2011-04-21 | 2011-06-01 | Glaxosmithkline Llc | Novel compounds |
GB201106750D0 (en) | 2011-04-21 | 2011-06-01 | Glaxosmithkline Llc | Novel compounds |
GB201107325D0 (en) | 2011-05-04 | 2011-06-15 | Glaxosmithkline Llc | Novel compounds |
SG11201506245QA (en) | 2013-03-14 | 2015-09-29 | Glaxosmithkline Ip No 2 Ltd | 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors |
-
2015
- 2015-09-09 PT PT15760461T patent/PT3191476T/pt unknown
- 2015-09-09 ES ES15760461T patent/ES2705623T3/es active Active
- 2015-09-09 RS RS20190001A patent/RS58135B1/sr unknown
- 2015-09-09 KR KR1020177008675A patent/KR20170054421A/ko unknown
- 2015-09-09 HU HUE15760461A patent/HUE041694T2/hu unknown
- 2015-09-09 SG SG11201701043UA patent/SG11201701043UA/en unknown
- 2015-09-09 CN CN201580048713.8A patent/CN106687453B/zh not_active Expired - Fee Related
- 2015-09-09 SI SI201530529T patent/SI3191476T1/sl unknown
- 2015-09-09 AU AU2015314184A patent/AU2015314184B2/en not_active Ceased
- 2015-09-09 MX MX2017003219A patent/MX2017003219A/es active IP Right Grant
- 2015-09-09 TR TR2018/20050T patent/TR201820050T4/tr unknown
- 2015-09-09 LT LTEP15760461.2T patent/LT3191476T/lt unknown
- 2015-09-09 WO PCT/EP2015/070665 patent/WO2016038120A1/en active Application Filing
- 2015-09-09 US US15/509,894 patent/US10059699B2/en active Active
- 2015-09-09 EA EA201790484A patent/EA031679B9/ru not_active IP Right Cessation
- 2015-09-09 PE PE2017000388A patent/PE20170675A1/es unknown
- 2015-09-09 BR BR112017004580-0A patent/BR112017004580A2/pt not_active Application Discontinuation
- 2015-09-09 PL PL15760461T patent/PL3191476T3/pl unknown
- 2015-09-09 JP JP2017513723A patent/JP6531167B2/ja not_active Expired - Fee Related
- 2015-09-09 CA CA2958159A patent/CA2958159A1/en not_active Abandoned
- 2015-09-09 EP EP15760461.2A patent/EP3191476B1/en active Active
- 2015-09-09 CR CR20170090A patent/CR20170090A/es unknown
- 2015-09-09 DK DK15760461.2T patent/DK3191476T3/en active
- 2015-09-09 MA MA040366A patent/MA40366A/fr unknown
- 2015-09-10 AR ARP150102888A patent/AR101806A1/es unknown
- 2015-09-10 UY UY0001036292A patent/UY36292A/es not_active Application Discontinuation
- 2015-09-10 TW TW104129977A patent/TWI686389B/zh not_active IP Right Cessation
-
2017
- 2017-02-01 IL IL250397A patent/IL250397A0/en unknown
- 2017-02-03 ZA ZA2017/00883A patent/ZA201700883B/en unknown
- 2017-02-17 CO CONC2017/0001601A patent/CO2017001601A2/es unknown
- 2017-02-27 PH PH12017500348A patent/PH12017500348A1/en unknown
- 2017-03-07 DO DO2017000058A patent/DOP2017000058A/es unknown
- 2017-03-09 CL CL2017000587A patent/CL2017000587A1/es unknown
-
2018
- 2018-12-06 HR HRP20182064TT patent/HRP20182064T1/hr unknown
-
2019
- 2019-01-15 CY CY20191100049T patent/CY1121369T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019500176A1 (en) | Heterocyclic compounds and ther uses | |
CL2017000654A1 (es) | Indazoles sustituidos con bencilo como inhibidores de bub1. | |
CL2016000925A1 (es) | Inhibidores de bromodominio | |
CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
CL2014003136A1 (es) | Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos. | |
GEP20217239B (en) | Pharmaceutical composition | |
BR112016015706A2 (pt) | composto, uso do mesmo e composição farmacêutica | |
CR20150524A (es) | Compuestos de heteroarilo y sus usos | |
CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
BR112016012146A8 (pt) | derivados de aminopiridina como inibidores de quinase da família tam | |
CL2017000587A1 (es) | Derivados de tetrahidroquinolina como inhibidores de bromodominio | |
MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
CO2018002211A2 (es) | Piridinona dicarboxamida para su uso como inhibidores de bromodominio | |
BR112016002859A2 (pt) | cápsula de segurança para recipientes | |
MX2015012416A (es) | Compuestos heterociclicos y sus usos. | |
GEP20217240B (en) | Pharmaceutical composition | |
CL2014001862A1 (es) | Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia. | |
GT201600252A (es) | Derivados de naftiridinadiona | |
MX2015008588A (es) | Composiciones y metodos para la transfeccion de polinucleótidos. | |
BR112017007753A2 (pt) | uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico. | |
BR112016020135A2 (pt) | mistura de composto, seus usos, composição farmacêutica, e conjunto (kit) | |
BR112016028017A2 (pt) | Inibidor de quinase alk e método de preparação e usos do mesmo | |
TH1501006784A (th) | องค์ประกอบทางเภสัชกรรมขนาดยาต่ำ |